AlphaYouWD
Insider selling
William D. Waddill sold Protagonist Therapeutics, Inc (PTGX) stock
William D. Waddill, Dir of Protagonist Therapeutics, Inc (PTGX), sold 9,000 shares of PTGX stock, per an SEC Form 4 filed Jun 1, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on May 29, 2026, 3 days before it was made public.
PTGX has moved +45.6% since the trade date, from $99.56 to $144.98 (Sep 21, 2026 close).
- Traded
- May 29, 2026
- Disclosed
- Jun 1, 2026
- Filing delay
- 3 days
- Price since
- +45.6%
- Role
- Dir
- Source
- SEC Form 4
More PTGX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.